# : Intravascular Injection Rates During Cervical Medial Branch Block

> **NCT05031936** · NA · COMPLETED · sponsor: **Keimyung University Dongsan Medical Center** · enrollment: 67 (actual)

## Conditions studied

- Vascular Complications

## Interventions

- **PROCEDURE:** cervical spinal injection with 0.2% ropivacaine

## Key facts

- **NCT ID:** NCT05031936
- **Lead sponsor:** Keimyung University Dongsan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-12
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05031936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05031936, ": Intravascular Injection Rates During Cervical Medial Branch Block". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05031936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*